Blog
RSS FeedPosted by Michael Wonder on 04 Oct 2022
Landmark PBS listing for treatment of gastro-oesophageal cancers
1 October 2022 - From 1 October, Australians with advanced or metastatic gastro-oesophageal cancers will have access to new treatment through ...
Posted by Michael Wonder on 03 Oct 2022
New Zealand Pharmaceutical Schedule - 1 October 2022
1 October 2022 - The October 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 Sep 2022
Schedule of Pharmaceutical Benefits - 1 October 2022
1 October 2022 - The October 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 26 Sep 2022
Patients will pay less for critical medicines including ‘miracle’ cancer drug
26 September 2022 - Australians will have cheaper access to medicines for migraines, arthritis, bipolar, stomach ulcers and several cancers. ...
Posted by Michael Wonder on 26 Sep 2022
Australians have access to more affordable and life changing medicines on PBS
26 September 2022 - From 1 October 2022, Australians will pay less at the pharmacy for new and updated medicines on ...
Posted by Michael Wonder on 19 Sep 2022
PHARMAC considering multiple new treatments from Takeda
19 September 2022 - Pharmac has initiated consultation today on a provisional bundle deal with Takeda to fund vedolizumab for people ...
Posted by Michael Wonder on 15 Sep 2022
Can the proposed listing of two medicines from the same supplier really be called a bundle deal?
16 September 2022 - On Wednesday, PHARMAC announced a "medicines bundle to provide more treatment options for New Zealanders." ...
Posted by Michael Wonder on 04 Sep 2022
Australia among world's best in treating debilitating and often fatal muscle disorder
4 September - Australia has become one of the first countries in the world to fund a new, next-generation treatment ...
Posted by Michael Wonder on 01 Sep 2022
Critical kidney disease medication listed on the PBS
1 September 2022 - A life changing treatment for chronic kidney disease will be made available to thousands of Australians through ...
Posted by Michael Wonder on 01 Sep 2022
Antengene announces Xpovia included for reimbursement by the PBS in Australia for the treatment of patients with relapsed and/or refractory multiple myeloma
1 September 2022 - Xpovio (selinexor) is the first and only selective inhibitor of nuclear export (SINE) inhibitor approved by the ...
Posted by Michael Wonder on 01 Sep 2022
PBS listing for ovarian cancer and kidney disease
1 September 2022 - From 1 September 2022, Australians will have access to new and expanded medicines on the Pharmaceutical Benefits ...
Posted by Michael Wonder on 31 Aug 2022
Kidney disease drug dapagliflozin added to Pharmaceutical Benefits Scheme
31 August 2022 - Lachlan Ross describes his more than a decade-long battle with kidney failure as "very long, and very ...
Posted by Michael Wonder on 31 Aug 2022
Schedule of Pharmaceutical Benefits - 1 September 2022
1 September 2022 - The September 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 Aug 2022
New Zealand Pharmaceutical Schedule - 1 September 2022 update
1 September 2022 - The September 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 Aug 2022
Spinal muscular atrophy community rejoices as 'life-changing' drug Spinraza approved for adults
30 August 2022 - "I have hope again," says Juanita Vernon as the 52 year old tearfully discusses her feelings about ...